The findings of the review were detailed during the latest PRAC meeting held this weekand theyre plenty reassuring.
In January, the FDAreportedthat its preliminary assessment had found no evidence of an increased suicide risk.
Of course, GLP-1s do have their drawbacks.
Ozempic injection pens.Image: Caroline Ruda (Shutterstock)
They commonly cause nausea and other gastrointestinal symptoms, for instance.
Theyve also been tied to other likelyrare but serious complicationssuch as gastroparesis.
The FDA said in January that it is still finalizing the results of its investigation.
News from the future, delivered to your present.